KR100630410B1 - Topical compositions of herbal extracts for prevention and cure of acne - Google Patents
Topical compositions of herbal extracts for prevention and cure of acne Download PDFInfo
- Publication number
- KR100630410B1 KR100630410B1 KR1020050031796A KR20050031796A KR100630410B1 KR 100630410 B1 KR100630410 B1 KR 100630410B1 KR 1020050031796 A KR1020050031796 A KR 1020050031796A KR 20050031796 A KR20050031796 A KR 20050031796A KR 100630410 B1 KR100630410 B1 KR 100630410B1
- Authority
- KR
- South Korea
- Prior art keywords
- extract
- acne
- acnes
- prevention
- treatment
- Prior art date
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/50—Fumariaceae (Fumitory family), e.g. bleeding heart
- A61K36/505—Corydalis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/58—Reptiles
- A61K35/586—Turtles; Tortoises, e.g. terrapins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/66—Papaveraceae (Poppy family), e.g. bloodroot
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/886—Aloeaceae (Aloe family), e.g. aloe vera
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
Abstract
Description
도 1은 본 발명의 귀판추출물의 농도별 P.acnes 에 대한 활성을 보여주는 것이다.Figure 1 shows the activity of P.acnes for each concentration of ear plate extract of the present invention.
도 2은 본 발명의 노회추출물의 농도별 P.acnes 에 대한 활성을 보여주는 것이다.Figure 2 shows the activity of P. acnes for each concentration of the extract of the present invention.
도 3은 본 발명의 마자인추출물의 농도별 P.acnes 에 대한 활성을 보여주는 것이다.Figure 3 shows the activity of P. acnes for each concentration of the extract as soon as the present invention.
도 4은 본 발명의 백굴채추출물의 농도별 P.acnes 에 대한 활성을 보여주는 것이다.Figure 4 shows the activity of P. acnes for each concentration of the extract of white buckwheat extract of the present invention.
도 5은 본 발명의 현호색추출물의 농도별 P.acnes 에 대한 활성을 보여주는 것이다.Figure 5 shows the activity of P. acnes for each concentration of corydalis extract of the present invention.
도 6a은 본 발명의 생약추출물을 팔 내측 피부에 적용한 직후 모습이다.Figure 6a is a state immediately after applying the herbal extract of the present invention to the inner skin of the arm.
도 6b는 본 발명의 생약추출물을 팔 내측 피부에 적용하고 48 시간 경과 후 모습이다.Figure 6b is after 48 hours after applying the herbal extract of the present invention to the inner skin of the arm.
여드름의 발생예방 및 치료를 위하여 피부 외용제로 사용되는 항미생물제로는 에리스로마이신, 클린다마이신, benzoyl peroxide 등이 있다. 그러나 상기 여드름 치료에 사용하는 항미생물제들은 내성균의 발생, 비선택적 살균 또는 정균작용 등의 문제점이 있다. 따라서 이러한 기존의 항미생물제를 대체할 수 있는 효과적인 물질을 찾는 것이 필요하다.Antimicrobial agents used as external preparations for the prevention and treatment of acne include erythromycin, clindamycin, and benzoyl peroxide. However, the antimicrobial agents used to treat the acne have problems such as generation of resistant bacteria, non-selective sterilization or bacteriostatic action. Therefore, there is a need to find an effective substance that can replace these existing antimicrobial agents.
본 발명자는 천연 대체물질을 선별하는 과정에서 귀판, 노회, 마자인, 백굴채, 현호색의 메탄올 추출물이 P. acnes 증식을 효과적으로 억제함을 확인하게 되었다. 본 발명의 생약추출물물 함유하는 조성물이 여드름 치료에 사용되는 기존의 항미생물제들을 대체하여 다수의 사람들에게 문제가 되고 있는 여드름을 예방 또는 치료할 수 있는 효과적인 수단을 제공할 수 있다.In the process of selecting natural substitutes, the inventors have found that the ear extract, presbyopia, mazain, white oyster and methanol extract of Hyunho color effectively inhibit P. acnes proliferation. The composition containing the herbal extract of the present invention may provide an effective means for preventing or treating acne, which is problematic for many people, by replacing the existing antimicrobial agents used in the treatment of acne.
본 발명은 P. acnes의 증식을 효과적으로 억제하여 여드름 발생의 예방 및 치료에 사용할 수 있는 P. acnes 증식억제능을 나타내는 귀판, 노회, 마자인, 백굴채, 현호색의 메탄올 추출물을 함유하는 조성물을 여드름 예방 및 치료제로 제공하고자 하는 것이다.The present invention effectively prevents the growth of P. acnes by preventing the acne outbreaks that exhibit P. acnes proliferation inhibitory ability that can be used for the prevention and treatment of acne, presence, mage, white oysters, a composition containing methanol extract of scallop And to provide as a therapeutic.
P. acnes의 증식억제 효과를 측정하기 위하여 BBL Gas Pack 혐기용 배양용기를 사용하였다. 시험균주는 Propionibacterium acnes KCTC3314이다.BBL Gas Pack anaerobic culture vessel was used to measure the growth inhibitory effect of P. acnes . The test strain was Propionibacterium acnes KCTC3314.
증식억제 효과측정에 사용한 생약들은 귀판, 노회, 마자인, 백굴채, 현호색이며, 각각의 생약 50g을 500 ml 의 메탄올로 환류냉각법으로 3시간 추출하여 용매를 제거한 후 잔사를 하기 실험의 시료로 사용하였다.The herbal medicines used for the measurement of growth inhibitory effect are ear plate, rosacea, mazain, white oyster, and navy color. 50 g of each herb was extracted with 500 ml of methanol for 3 hours by reflux cooling to remove the solvent, and the residue was used as a sample for the following experiment. It was.
생약추출물의 여드름 원인균의 증식억제 효과를 실험하기위하여 상기 생약추출물 50mg을 증류수 1ml에 현탁하여 시료액으로 사용하였다.To test the growth inhibitory effect of the acne causative bacteria of the herbal extracts were suspended 50mg of the herbal extracts in 1ml of distilled water was used as a sample solution.
P. acnes의 배양에 사용한 배지는 Actinomyces broth agar 배지이었다. The medium used for culturing P. acnes was Actinomyces broth agar medium.
미생물의 배양은 섭씨 37도 항온 배양기에서 실시하였다.The microorganisms were cultured in a 37 ° C. incubator.
실시 예 1. 귀판추출물의 P. acnes에 대한 증식억제 효과Example 1 Inhibitory Effect of Ear Disc Extract on P. acnes
귀판 추출물 50mg을 증류수 1ml에 현탁하고 원심분리하여 상등액을 40, 20, 10 ㎕ 각각을 Actinomyces broth agar 배지 4ml에 혼합하여 평판배지를 만들고 배양된 P. acnes 미생물을 멸균 증류수에 현탁하여 A600이 0.1되게 하여 피펫맨을 이용하여 3㎕접종하고 배양하여 균의 증식을 관찰하였다. 실험결과는 도 1과 같았다.50 mg of ear plate extract is suspended in 1 ml of distilled water and centrifuged. The supernatant is mixed with 4 ml of Actinomyces broth agar medium, and the plated medium is made. The cultured P. acnes microorganisms are suspended in sterile distilled water and A 600 is 0.1 3 µl inoculation was carried out using Pipetman and cultured to observe the growth of the bacteria. Experimental results were as shown in FIG.
실시 예 2. 노회추출물의 P. acnes에 대한 증식억제 효과Example 2 Growth Inhibition Effects of P. acnes Extracts from
노회 추출물 50mg을 증류수 1ml에 현탁하고 원심분리하여 상등액을 60, 40, 20 ㎕ 각각을 Actinomyces broth agar 배지 4ml에 혼합하여 평판배지를 만들고 배양된 P. acnes 미생물을 멸균 증류수에 현탁하여 A600이 0.1되게 하여 피펫맨을 이용하여 3㎕접종하고 배양하여 균의 증식을 관찰하였다. 실험결과는 도 2와 같았다.By suspending the classis extract 50mg in 1ml of distilled water, and centrifugation the supernatant was mixed with 60, 40, 20 ㎕ respectively in Actinomyces broth agar medium 4ml making the plate medium were suspended in sterile distilled water in cultured P. acnes microorganisms yi A 600 0.1 3 µl inoculation was carried out using Pipetman and cultured to observe the growth of the bacteria. Experimental results were as shown in FIG.
실시 예 3. 마자인추출물의 P. acnes에 대한 증식억제 효과Example 3 Growth Inhibition Effect of P. acnes of Mazarine Extracts
마자인 추출물 50mg을 증류수 1ml에 현탁하고 원심분리하여 상등액을 60, 40, 20 ㎕ 각각을 Actinomyces broth agar 배지 4ml에 혼합하여 평판배지를 만들고 배양된 P. acnes 미생물을 멸균 증류수에 현탁하여 A600이 0.1되게 하여 피펫맨을 이용하여 3㎕접종하고 배양하여 균의 증식을 관찰하였다. 실험결과는 도 3와 같았다.Suspended 50 mg of the extract in 1 ml of distilled water and centrifuged to mix the
실시 예 4. 백굴채추출물의 P. acnes에 대한 증식억제 효과Example 4 Growth Inhibition Effect of P. acnes Extract
백굴채 추출물 50mg을 증류수 1ml에 현탁하고 원심분리하여 상등액을 60, 40, 20 ㎕ 각각을 Actinomyces broth agar 배지 4ml에 혼합하여 평판배지를 만들고 배양된 P. acnes 미생물을 멸균 증류수에 현탁하여 A600이 0.1되게 하여 피펫맨을 이용하여 3㎕접종하고 배양하여 균의 증식을 관찰하였다. 실험결과는 도 4와 같았다.50 mg of Baekgulchae extract was suspended in 1 ml of distilled water and centrifuged. The supernatant was mixed with 4, 60 ml of Actinomyces broth agar medium, and the plated medium was made. The cultured P. acnes microorganisms were suspended in sterile distilled water to give A 600 . 0.1 μl was used to inoculate 3 μl using Pipetman and cultured to observe the growth of the bacteria. Experimental results were as shown in FIG.
실시 예 5. 현호색추출물의 P. acnes에 대한 증식억제 효과Example 5 Growth Inhibition Effect of Corydalis Root Extract on P. acnes
현호색 추출물 50mg을 증류수 1ml에 현탁하고 원심분리하여 상등액을 60, 40, 20 ㎕ 각각을 Actinomyces broth agar 배지 4ml에 혼합하여 평판배지를 만들고 배양된 P. acnes 미생물을 멸균 증류수에 현탁하여 A600이 0.1되게 하여 피펫맨을 이용하여 3㎕접종하고 배양하여 균의 증식을 관찰하였다. 실험결과는 도 5와 같았다.By suspending the Corydalis extract 50mg in 1ml of distilled water, and centrifugation the supernatant was mixed with 60, 40, 20 ㎕ respectively in Actinomyces broth agar medium 4ml making the plate medium were suspended in sterile distilled water in cultured P. acnes microorganisms yi A 600 0.1 3 µl inoculation was carried out using Pipetman and cultured to observe the growth of the bacteria. Experimental results were as shown in FIG.
이상의 실시 예에서 보는바와 같이 귀판, 뇌회, 마자인, 백굴채, 현호색 추출물은 낮은 농도에서 여드름 생성 원인균인 P. acnes를 효과적으로 억제함을 알 수 있어, 이들을 여드름 예방 및 치료에 사용할 수 있음을 알 수 있다.As can be seen from the above examples, ear plate, sashimi, madin, baekryechae, hyacinth extract can be found to effectively inhibit P. acnes , the cause of acne-producing bacteria at low concentrations, so that they can be used for the prevention and treatment of acne. Can be.
참고로 항미생물제로 임상에서 여드름의 예방 치료에 사용되는 농도는 에리스로마이신 1.5 - 3.0 %, 클린다마이신은 1 %, benzoyl peroxide 5 % 이다.For reference, the concentration of antimicrobial agents used in prophylactic treatment of acne in the clinic is 1.5-3.0% for erythromycin, 1% for clindamycin, and 5% for benzoyl peroxide.
따라서 본 발명의 귀판, 노회, 마자인, 백굴채, 현호색 추출물을 1종 이상 함유하는 본발명의 조성물은 종래의 여드름 치료에 사용되는 기존의 항미생물제의 대용으로 여드름 원인균의 증식을 억제할 수 있어 종래 항생물질의 사용에 기인하는 피부영향을 최소화하면서 효과적인 여드름 예방 및 치료제를 제공할 수 있다.Therefore, the composition of the present invention containing one or more of the ear plate, presbyopia, mazain, baekryechae, Hyunho color extract of the present invention can inhibit the growth of acne-causing bacteria by substituting conventional antimicrobial agents used in conventional acne treatment It is possible to provide an effective acne prevention and treatment agent while minimizing the skin effects resulting from the use of conventional antibiotics.
시험 예 1Test Example 1
귀판, 노회, 마자인, 백굴채, 현호색 추출물의 피부적용성을 시험하기위하여 피부 안전성 시험을 0.01 %에서 5 %의 농도에서 접촉성 피부염 유발효과를 측정하였다. 팔의 내 측면에 지름이 추출물 현탁액 50 ㎕을 부과하고(도 6a), 48시간 이후에 발적 여부를(도 6b) 살펴 자극여부를 20명의 사람에서 검사하였다. 표 1에서 볼 수 있듯이 접촉성 피부염 유발 가능성은 없었다.In order to test the skin applicability of ear plate, presbyopia, mazain, baekryechae, and calendula extract, the skin safety test was performed to determine the effect of contact dermatitis at concentrations of 0.01% to 5%. 50 μl of the diameter of the suspension suspension was imposed on the inner side of the arm (FIG. 6A), and after 48 hours, redness was examined (FIG. 6B) to examine irritation in 20 people. As shown in Table 1, there was no possibility of causing contact dermatitis.
본 발명의 여드름 예방 및 치료제의 제형은 크림제제, 로션제제, 용액제제 등 피부에 외용으로 적용할 수 있는 제형이라면 어느 것이나 좋으며, 통상의 제제화 방법으로 제공될 수 있다.The formulation of the acne preventive and therapeutic agent of the present invention may be any formulation that can be applied externally to the skin such as cream, lotion, solution, etc., and may be provided by a conventional formulation method.
제제 예 1Formulation Example 1
제제의 일예로 로션제제를 예시하면 다음과 같다.(단위 중량%)An example of a lotion formulation as an example of the formulation is as follows (unit weight percent).
노회 추출물 0.1 %, 스테아릭산 0.5 %, 세타놀 1.2 %, 글리세릴 트리옥타노에트 1.5 %, 스쿠알레인 2.0 %, 프로필 파라벤 0.1 %, 부틸 파라벤 0.05 %, 디메치콘 0.3 %, 솔비탄 세스키올레이트0.2 %, 투인 60 0.3 %, 글리세린 7.0 %, 이미다졸리디닐 유레아 0.15 %, 트리에탄올아민 0.15 %, 카보머 0.1 %, 증류수 적량.Crude Extract 0.1%, Stearic Acid 0.5%, Cetanol 1.2%, Glyceryl Trioctanoate 1.5%, Squalane 2.0%, Propyl Paraben 0.1%, Butyl Paraben 0.05%, Dimethicone 0.3%, Solbitan Seskiol 0.2%, Tuin 60 0.3%, Glycerin 7.0%, Imidazolidinyl urea 0.15%, Triethanolamine 0.15%, Carbomer 0.1%, Distilled water appropriate amount.
시험 예 2Test Example 2
제제 예 1에 대하여 여드름 발생 예방과 치료에 대한 효능 품평 시험을 성인 10명에 대하여 실시한 결과는 아래와 같다. 여드름 예방과 치료에서 노회 추출물이 0.1 % 첨가된 로션제제를 아침과 저녁 1일 2회 세안 후 피부에 10일 간 적용한 결과는 아래 표 2와 같이 여드름 발생예방, 여드름 개선, 화농 억제 등에서 70 %이상의 효과를 보였다.The results of the evaluation of the efficacy evaluation on the prevention and treatment of acne outbreak for 10 adults of Formulation Example 1 are as follows. In the prevention and treatment of acne, a lotion preparation containing 0.1% of the extract was applied to the skin for 10 days after washing twice a day in the morning and evening, as shown in Table 2 below. It showed an effect.
따라서 본 발명에 적용하는 외용제로서의 귀판, 노회, 마자인, 백굴채, 현호색 추출물의 바람직한 농도는 여드름 예방 및 치료효과를 기대할 수 있고 피부자극이 없는 농도인 0.1중량 % ~ 1 중량 %가 적합하나 필요에 따라서 10 중량 % 까지 사용할 수도 있다.Therefore, the preferred concentrations of ear extract, rosacea, mazain, baekryechae, Hyunho-red extract as external preparations to be applied to the present invention are expected to be effective in preventing and treating acne. In some cases, up to 10% by weight may be used.
0.1 중량 % 이하로 사용하면 본 발명의 바람직한 효과를 기대하기 어렵고 10 중량 % 이상 사용하면 추가의 효과를 기대할 수 없어 바람직하지 않다.If it is used at 0.1% by weight or less, it is difficult to expect the desirable effects of the present invention. If it is used at 10% by weight or more, further effects cannot be expected, which is not preferable.
여드름 예방과 치료를 위해서는 상기 외용제를 아침과 저녁 1일 2회 세안 후 피부에 적용하는 것이 바람직하다.For the prevention and treatment of acne, it is preferable to apply the external preparation to the skin after washing twice a day in the morning and evening.
낮은 농도에서 P. acnes 세균의 증식을 억제하는 귀판, 노회, 마자인, 백굴채, 현호색 추출물이 함유된 천연 여드름 예방 및 치료제를 제공함으로써 사람의 삶의 질 향상 에 기여할 수 있다. It can contribute to improving the quality of life of humans by providing natural acne prevention and treatments containing ear extract, presbyopia, mazain, white oyster, and corydalis extract at low concentrations that inhibit the growth of P. acnes bacteria.
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020050031796A KR100630410B1 (en) | 2005-04-18 | 2005-04-18 | Topical compositions of herbal extracts for prevention and cure of acne |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020050031796A KR100630410B1 (en) | 2005-04-18 | 2005-04-18 | Topical compositions of herbal extracts for prevention and cure of acne |
Publications (1)
Publication Number | Publication Date |
---|---|
KR100630410B1 true KR100630410B1 (en) | 2006-10-12 |
Family
ID=37626002
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020050031796A KR100630410B1 (en) | 2005-04-18 | 2005-04-18 | Topical compositions of herbal extracts for prevention and cure of acne |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100630410B1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101299213B1 (en) | 2006-12-26 | 2013-08-21 | 주식회사 코리아나화장품 | Cosmetic Composition Comprising the Extract of Eucommia ulmoides, Geranium nepalense and Chelidonium majus As Preservatives |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5464510A (en) * | 1977-11-01 | 1979-05-24 | Nippon Chemical Ind | Sprayable refractory binder |
JP2001322943A (en) * | 2000-05-12 | 2001-11-20 | Kao Corp | Prophylactic and therapeutic agent for pimple |
KR20040018684A (en) * | 2002-08-26 | 2004-03-04 | 한불화장품주식회사 | composition of skin agent containing extract of Fumariaceae |
KR20040033945A (en) * | 2002-10-16 | 2004-04-28 | (주)바이오나노텍 | Materials containing Soap aloe(African aloe) of cosmatics made for a pimpled face |
KR20050080882A (en) * | 2004-02-11 | 2005-08-18 | 채규윤 | A antiinflammatory composition containing stylopine isolated from leaf of chelidonium majus |
-
2005
- 2005-04-18 KR KR1020050031796A patent/KR100630410B1/en not_active IP Right Cessation
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5464510A (en) * | 1977-11-01 | 1979-05-24 | Nippon Chemical Ind | Sprayable refractory binder |
JP2001322943A (en) * | 2000-05-12 | 2001-11-20 | Kao Corp | Prophylactic and therapeutic agent for pimple |
KR20040018684A (en) * | 2002-08-26 | 2004-03-04 | 한불화장품주식회사 | composition of skin agent containing extract of Fumariaceae |
KR20040033945A (en) * | 2002-10-16 | 2004-04-28 | (주)바이오나노텍 | Materials containing Soap aloe(African aloe) of cosmatics made for a pimpled face |
KR20050080882A (en) * | 2004-02-11 | 2005-08-18 | 채규윤 | A antiinflammatory composition containing stylopine isolated from leaf of chelidonium majus |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101299213B1 (en) | 2006-12-26 | 2013-08-21 | 주식회사 코리아나화장품 | Cosmetic Composition Comprising the Extract of Eucommia ulmoides, Geranium nepalense and Chelidonium majus As Preservatives |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Koo et al. | Effects of apigenin and tt‐farnesol on glucosyltransferase activity, biofilm viability and caries development in rats | |
Wintola et al. | The antibacterial, phytochemicals and antioxidants evaluation of the root extracts of Hydnora africana Thunb. used as antidysenteric in Eastern Cape Province, South Africa | |
Goodwin et al. | Prevention of nitroimidazole resistance in Campylobacter pylori by coadministration of colloidal bismuth subcitrate: clinical and in vitro studies. | |
Qiao et al. | Antioxidant activities of polysaccharides from Hyriopsis cumingii | |
KR100847103B1 (en) | Fermented guava composition and use thereof | |
Bafna et al. | Anti-ulcer and antioxidant activity of DHC-1, a herbal formulation | |
Varanda et al. | Inhibitory effect of propolis and bee venom on the mutagenicity of some direct‐and indirect‐acting mutagens | |
Tempera et al. | Inhibitory activity of cranberry extract on the bacterial adhesiveness in the urine of women: an ex-vivo study | |
Zi et al. | Antioxidant action and protective and reparative effects of lentinan on oxidative damage in HaCaT cells | |
KR20060114370A (en) | Skin treatment method with lactobacillus extract | |
KR20060005356A (en) | Compositions comprising lactobacillus plantarum strains in combination with tannin and new lactobacillus plantarum strains | |
Bhamarapravati et al. | Antibacterial activity of Boesenbergia rotunda (L.) Mansf. and Myristica fragrans Houtt. against Helicobacter pylori | |
JP6839329B2 (en) | Composition for the management of Helicobacter pylori infection | |
Salar et al. | Antimicrobial and free radical scavenging activity of extracts of some Indian medicinal plants | |
KR20130135597A (en) | Composition of cosmetic | |
KR101202367B1 (en) | Anti-acne composition containing a Nuruk ferment of Sophora flower extract | |
Nwaokorie et al. | Antimicrobial activities of Garcinia kola on oral Fusobacterium nucleatum and biofilm | |
CN109394598A (en) | A kind of anti-acne concentrate and its application | |
KR20130048946A (en) | Anti-cancer composition comprising lactobacillus reuteri cs132 or culture fluid of thereof | |
WO2018194327A2 (en) | Novel marine-derived microorganism and cosmetic composition using same | |
KR100630410B1 (en) | Topical compositions of herbal extracts for prevention and cure of acne | |
Mustofa | Active compounds isolated from red betel (Piper crocatum Ruiz & Pav) leaves active against Streptococcus mutans through its inhibition effect on glucosyltransferase activity | |
RU2640928C2 (en) | Combination of fulvic acid and antibiotic for suppression of growth of bacteria resistant to majority of drugs, or treatment of infections caused by them | |
KR100526992B1 (en) | Fermented extract of a fruit of the trifoliate orange, and a composition for treating the disease caused by infection of helicobacter pylori | |
KR102350437B1 (en) | Cosmetic compositions containing Hwangryunhaedoktang fermented with Lactobacillus plantarum WiKim0111 for anti-acne |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E701 | Decision to grant or registration of patent right | ||
N231 | Notification of change of applicant | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20120829 Year of fee payment: 7 |
|
FPAY | Annual fee payment |
Payment date: 20130826 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20140901 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20150916 Year of fee payment: 10 |
|
LAPS | Lapse due to unpaid annual fee |